Madhav V. Dhodapkar, MBBS

Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Director of Hematologic Malignancies, Yale Cancer Center


Departments & Organizations

Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Cancer Center, Yale: Hematology Program | Cancer Immunology

Immunobiology

Hematology

Biography

Medical School: All India Instt. of Medical Sciences, New Delhi, India
Fellowship (Hematology / Oncology): Mayo Clinic, Rochester, MN

Prior Faculty appointments: Myeloma Institute, Little Rock, AR; Memorial Sloan Kettering Cancer Center, New York, NY; The Rockefeller University, New York, NY

Research Interests: Immunobiology of myeloma; Development of novel biological approaches to treat cancer; dendritic cell biology

Education

  • M.B.B.S., All India Institute of Medical Sciences, New Delhi, 1987

Selected Publication

  • Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FC? receptor (Fc?RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.